CLASS I Drug recall · Reported 27 Aug 2014 · FDA Enforcement Report

DOBUTamine Injection, USP, 250 mg per Single-dose Fliptop Vial recalled

Hospira is recalling DOBUTamine Injection, USP, 250 mg per Single-dose Fliptop Vial, distributed nationwide in the US. The recall was initiated on 10 Jan 2014 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot # 27-352-DK; Exp 03/15
NDC0409-2344
Quantity recalled123,900 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1540-2014
FDA event ID
67354
Recalling firm
Hospira, Lake Forest, IL
Manufacturer
Hospira, Inc.
Classification
Class I
Status
Terminated
Recall initiated
10 Jan 2014
FDA classified
18 Aug 2014
Reported
27 Aug 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter

Timeline

10 Jan 2014Recall initiated by company
18 Aug 2014Classified by FDA+220 days
27 Aug 2014Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter: Discolored solution due to a chip in the glass at the neck of the vial, also glass particulate was found within the solution.

Product as listed by the FDA

DOBUTamine Injection, USP, 250 mg per 20 mL, 20 mL Single-dose Fliptop Vial, Rx only, Manufactured for Hospira Inc., Lake Forest, IL 60045 USA. NDC 0409-2344-02

Where it was distributed

Nationwide and Puerto Rico.

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Presence of Particulate Matter: Discolored solution due to a chip in the glass at the neck of the vial, also glass particulate was found within the solution.

Which lots are affected?

Lot # 27-352-DK; Exp 03/15

Where was it sold?

Nationwide and Puerto Rico.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Hospira

All 225

Other Dobutamine recalls

All 7